These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11736869)

  • 1. Effect of alosetron on theophylline pharmacokinetics.
    Koch KM; Ricci BM; Hedayetullah NS; Jewell D; Kersey KE
    Br J Clin Pharmacol; 2001 Nov; 52(5):596-600. PubMed ID: 11736869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers.
    Peng WX; Li HD; Zhou HH
    Eur J Clin Pharmacol; 2003 Jul; 59(3):237-41. PubMed ID: 12756512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
    Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of pharmacokinetics of theophylline by antofloxacin, a novel 8-amino-fluoroquinolone, in humans.
    Liu L; Pan X; Liu HY; Liu XD; Yang HW; Xie L; Cheng JL; Fan HW; Xiao DW
    Acta Pharmacol Sin; 2011 Oct; 32(10):1285-93. PubMed ID: 21892200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tegaserod coadministration does not alter the pharmacokinetics of theophylline in healthy subjects.
    Zhou H; Khalilieh S; Svendsen K; Pommier F; Osborne S; Appel-Dingemanse S; Lasseter K; McLeod JF
    J Clin Pharmacol; 2001 Sep; 41(9):987-93. PubMed ID: 11549104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study investigating pharmacokinetic interaction between theophylline and roflumilast in healthy adults.
    Böhmer G; Gleiter CH; Hünnemeyer A; Lahu G; Bethke TD
    Int J Clin Pharmacol Ther; 2011 Jul; 49(7):451-60. PubMed ID: 21726496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men.
    Macias WL; Bergstrom RF; Cerimele BJ; Kassahun K; Tatum DE; Callaghan JT
    Pharmacotherapy; 1998; 18(6):1237-48. PubMed ID: 9855322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of zileuton on theophylline pharmacokinetics.
    Granneman GR; Braeckman RA; Locke CS; Cavanaugh JH; Dubé LM; Awni WM
    Clin Pharmacokinet; 1995; 29 Suppl 2():77-83. PubMed ID: 8620674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alosetron on the pharmacokinetics of fluoxetine.
    D'Souza DL; Dimmitt DC; Robbins DK; Nezamis J; Simms L; Koch KM
    J Clin Pharmacol; 2001 Apr; 41(4):455-8. PubMed ID: 11304903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ranitidine on theophylline metabolism in healthy Koreans living in China.
    Kehoe WA; Sands CD; Long LF; Lan HH; Harralson AF; Shin HT; Jones DW
    Ann Pharmacother; 1996 Feb; 30(2):133-7. PubMed ID: 8835044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic changes of unbound theophylline are due to plasma protein binding displacement and CYP1A2 activity inhibition by baicalin in rats.
    Gao N; Fang Y; Qi B; Jia LJ; Jin H; Qiao HL
    J Ethnopharmacol; 2013 Nov; 150(2):477-84. PubMed ID: 24076258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of montelukast on single-dose theophylline pharmacokinetics.
    Malmstrom K; Schwartz J; Reiss TF; Sullivan TJ; Reese JH; Jauregui L; Miller K; Scott M; Shingo S; Peszek I; Larson P; Ebel D; Hunt TL; Huhn RD; Bachmann K
    Am J Ther; 1998 May; 5(3):189-95. PubMed ID: 10099058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alosetron on the pharmacokinetics of alprazolam.
    D'Souza DL; Levasseur LM; Nezamis J; Robbins DK; Simms L; Koch KM
    J Clin Pharmacol; 2001 Apr; 41(4):452-4. PubMed ID: 11304902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No pharmacokinetic or pharmacodynamic interaction between theophylline and the leukotriene biosynthesis inhibitor BAY x 1005.
    Groen H; Moesker HL; Leeuwenkamp OR; Sollie FA; Jonkman JH
    J Clin Pharmacol; 1996 Jul; 36(7):639-46. PubMed ID: 8844447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probe.
    Bachmann K; White D; Jauregui L; Schwartz JI; Agrawal NG; Mazenko R; Larson PJ; Porras AG
    J Clin Pharmacol; 2003 Oct; 43(10):1082-90. PubMed ID: 14517190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease.
    Dockens RC; Rapoport D; Roberts D; Greene DS; Barbhaiya RH
    Br J Clin Pharmacol; 1995 Dec; 40(6):598-601. PubMed ID: 8703669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alosetron (a new 5-HT3 receptor antagonist) on the pharmacokinetics of haloperidol in schizophrenic patients.
    Gupta SK; Kunka RL; Metz A; Lloyd T; Rudolph G; Perel JM
    J Clin Pharmacol; 1995 Feb; 35(2):202-7. PubMed ID: 7751433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herb-drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats.
    Tang J; Sun J; Zhang Y; Li L; Cui F; He Z
    Food Chem Toxicol; 2007 Dec; 45(12):2441-5. PubMed ID: 17681658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alosetron repeat dose pharmacokinetics, effects on enzyme activities, and influence of demographic factors.
    Koch KM; Corrigan BW; Manzo J; James CD; Scott RJ; Stead AG; Kersey KE
    Aliment Pharmacol Ther; 2004 Jul; 20(2):223-30. PubMed ID: 15233703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the route of 1-methylurate formation in theophylline metabolism.
    Bayar C; Ozer I
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):415-9. PubMed ID: 9512943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.